EUVIMEDEUVIMED entdecken
Open Access

The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells

Michelle C Barbeau iD, Brooke A Brown iD, Sara J Adair iD, Todd W Bauer iD, Matthew J Lazzara iD

Science Signaling · 2025

DOI: 10.1126/scisignal.ads7002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Michelle C Barbeau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Virginia, Charlottesville, VA 22903, USA. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Pancreatic Neoplasms, MAP Kinase Signaling System, Extracellular Signal-Regulated MAP Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial-mesenchymal transition (EMT) occurs heterogeneously among carcinoma cells to promote chemoresistance. Identifying the signaling pathways involved will nominate drug combinations to promote chemoresponse, but cell population–level studies can be misleading, and single-cell transcriptomics are limited to indirect ontology-based inferences. To understand EMT heterogeneity at a signaling protein level, we combined iterative indirect immunofluorescence imaging of pancreas cancer cells and tumors and mutual information (MI) analysis. Focusing first on mitogen-activated protein kinase pathways, MI indicated that cell-to-cell variation in ERK activity determined EMT heterogeneity in response to different growth factors and chemotherapeutics but that JNK compensated when MEK was inhibited. Population-level models could not capture these experimentally validated MI inferences. The dominant role of ERK was consistently indicated by MI even when the analysis was expanded to include seven potential EMT-regulating signaling nodes. More generally, this work provides an approach for studying multivariate signaling-phenotype relationships based on protein measurements in any setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionPancreatic NeoplasmsMAP Kinase Signaling SystemExtracellular Signal-Regulated MAP KinasesHumansCell Line, TumorSignal Transduction

Substanzen

Extracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Department of Pathology, University of Virginia, Charlottesville, VA 22903, USA.
  • Department of Chemical Engineering, University of Virginia, Charlottesville, VA 22903, USA.
  • Department of Surgery, University of Virginia, Charlottesville, VA 22903, USA.
  • Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22903, USA.

ORCID-Profile: Michelle C Barbeau, Brooke A Brown, Sara J Adair, Todd W Bauer, Matthew J Lazzara

Förderung

  • NCI NIH HHS

Zitieren

APA

Barbeau, M. C., Brown, B. A., Adair, S. J., Bauer, T. W., & Lazzara, M. J. (2025). The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells. Science Signaling. https://doi.org/10.1126/scisignal.ads7002

Vancouver

Barbeau MC, Brown BA, Adair SJ, Bauer TW, Lazzara MJ. The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells. Science Signaling. 2025. doi:10.1126/scisignal.ads7002

BibTeX
@article{Barbeau2025,
  author = {Barbeau, Michelle C and Brown, Brooke A and Adair, Sara J and Bauer, Todd W and Lazzara, Matthew J},
  title = {The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells},
  journal = {Science Signaling},
  year = {2025},
  doi = {10.1126/scisignal.ads7002}
}
Kostenlos starten →